Tp0006 50243 — Boston, Massachusetts

Tp0006 50243 is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Tp0006 50243 has participated in 1 clinical trials.

Therapeutic areas: Primary Immune Thrombocytopenia.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tp0006 50243?

Tp0006 50243 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tp0006 50243 conducted?

Tp0006 50243 has 1 clinical trials on record. Their work covers Primary Immune Thrombocytopenia.

Is Tp0006 50243 accredited by Crixeo Health?

Tp0006 50243 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tp0006 50243?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.